title: Is post-exposure prophylaxis affordable?
authors.forename: S D
authors.initials: SD
authors.lastname: Pinkerton
authors.forename: D R
authors.initials: DR
authors.lastname: Holtgrave
authors.forename: J G
authors.initials: JG
authors.lastname: Kahn
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012747:Sexual Partners; D014481:United States
chemical_list: D019380:Anti-HIV Agents